Scorpion Therapeutics

Scorpion Therapeutics was founded to expand the scope and impact of precision medicine to more cancer patients. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0.Scorpion Therapeutics' experienced leadership team is implementing a purpose-driven model to effectively unlock the next generation of precision oncology. The company’s team consists of renowned experts in the fields of cancer biology, targeted oncology, and drug development, who excel in cataloging and understanding genomic events and cellular mechanisms that cause cancer; identifying and characterizing molecular subtypes of diseases; designing pharmacological interventions to halt these disease processes, and accelerating the clinical translation of new insights into targeted therapies for patients.